Protein phosphatase 2A impairs IFNα-induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylation

被引:28
|
作者
Shanker, V. [1 ,2 ]
Trincucci, G. [1 ,2 ]
Heim, H. M. [1 ,2 ,3 ]
Duong, H. T. F. [1 ,2 ]
机构
[1] Univ Basel, Dept Biomed, Basel, Switzerland
[2] Univ Basel Hosp, CH-4031 Basel, Switzerland
[3] Univ Basel, Div Gastroenterol & Hepatol, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
antiviral activity; HCV replication; interferon alpha; protein phosphatase 2A; STAT1; UP-REGULATION; ARGININE METHYLATION; ACTIVATION; PP2A; SUBUNIT; TRANSCRIPTION; HOLOENZYMES; ENZYME;
D O I
10.1111/jvh.12083
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mammalian cells have developed several mechanisms to sense viruses and initiate adequate responses such as production of interferons. Interferons activate the antiviral response through the Jak-STAT signalling pathway. To establish a chronic infection, viruses need to counteract this barrier of defence. The hepatitis C and hepatitis B viruses are known to up-regulate the expression of protein phosphatase 2A (PP2A). In this study, we show that PP2Ac associates with Jak1/Tyk2/STAT1 and reduces Jak1/Tyk2/STAT1 phosphorylation resulting in an impairment of the IFN alpha-induced HCV antiviral response. Using the fully infectious HCV cell culture system (HCVcc), we demonstrate that the PP2A catalytic activity is not required to block the antiviral effect of IFN alpha, although it is needed to support HCVcc replication. Our data suggest an important contribution of virus-induced PP2Ac up-regulation in the establishment of a chronic infection.
引用
收藏
页码:612 / 621
页数:10
相关论文
共 50 条
  • [41] Novel alpha interferon (IFN-α) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-α2b therapy in a subgenomic replicon system
    Escuret, Vanessa
    Martin, Amaury
    Durantel, David
    Parent, Romain
    Hantz, Olivier
    Trepo, Christian
    Menguy, Thierry
    Bottius, Emmanuel
    Dardy, Jerome
    Maral, Jean
    Escary, Jean Louis
    Zoulim, Fabien
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) : 3984 - 3991
  • [42] Ribavirin Enhances the Action of Interferon-α against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway
    Liu, Wei-Liang
    Yang, Hung-Chih
    Su, Wen-Cheng
    Wang, Chih-Chiang
    Chen, Hui-Ling
    Wang, Hurng-Yi
    Huang, Wen-Hung
    Chen, Ding-Shinn
    Lai, Ming-Yang
    PLOS ONE, 2012, 7 (09):
  • [43] Modulation of GABAA receptor phosphorylation and membrane trafficking by phospholipase C-related inactive protein/protein phosphatase 1 and 2A signaling complex underlying brain-derived neurotrophic factor-dependent regulation of GABAergic inhibition
    Kanematsu, Takashi
    Yasunaga, Atsushi
    Mizoguchi, Yoshito
    Kuratani, Akiko
    Kittler, Josef T.
    Jovanovic, Jasmina N.
    Takenaka, Kei
    Nakayama, Keiichi I.
    Fukami, Kiyoko
    Takenawa, Tadaomi
    Moss, Stephen J.
    Nabekura, Junichi
    Hirata, Masato
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (31) : 22180 - 22189
  • [44] Destabilization of PDK1 by Hsp90 inactivation suppresses hepatitis C virus replication through inhibition of PRK2-mediated viral RNA polymerase phosphorylation
    Kim, Mi-Gyeong
    Moon, Jae-Su
    Kim, Eun-Jung
    Lee, Seung-Hoon
    Oh, Jong-Won
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 421 (01) : 112 - 118
  • [45] Cleavage of the T Cell Protein Tyrosine Phosphatase by the Hepatitis C Virus Nonstructural 3/4A Protease Induces a Th1 to Th2 Shift Reversible by Ribavirin Therapy
    Brenndoerfer, Erwin Daniel
    Brass, Anette
    Karthe, Juliane
    Ahlen, Gustaf
    Bode, Johannes Georg
    Saellberg, Matti
    JOURNAL OF IMMUNOLOGY, 2014, 192 (04): : 1671 - 1680
  • [46] Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy
    Watanabe, H
    Nagayama, K
    Enomoto, N
    Itakura, J
    Tanabe, Y
    Sato, C
    Izumi, N
    Watanabe, M
    HEPATOLOGY RESEARCH, 2003, 26 (04) : 268 - 274
  • [47] THE HEPATITIS C VIRUS NON-STRUCTURAL 3/4A PROTEASE MEDIATES AN INTRAHEPATIC T HELPER(Th)-1 TO Th2 SHIFT BY CLEAVING THE T CELL PROTEIN TYROSINE PHOSPHATASE
    Brenndorfer, E. D.
    Brass, A.
    Karthe, J.
    Ahlen, G.
    Bode, J. G.
    Sallberg, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S134 - S134
  • [48] Myeloid-Cell Protein Tyrosine Phosphatase-1B Deficiency in Mice Protects Against High-Fat Diet and Lipopolysaccharide-Induced Inflammation, Hyperinsulinemia, and Endotoxemia Through an IL-10 STAT3-Dependent Mechanism
    Grant, Louise
    Shearer, Kirsty D.
    Czopek, Alicja
    Lees, Emma K.
    Owen, Carl
    Agouni, Abdelali
    Workman, James
    Martin-Granados, Cristina
    Forrester, John V.
    Wilson, Heather M.
    Mody, Nimesh
    Delibegovic, Mirela
    DIABETES, 2014, 63 (02) : 456 - 470
  • [49] Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway
    Jackel-Cram, Candice
    Qiao, Ling
    Xiang, Zhongua
    Brownlie, Robert
    Zhou, Yan
    Babiuk, Lorne
    Liu, Qiang
    JOURNAL OF GENERAL VIROLOGY, 2010, 91 : 1388 - 1395
  • [50] Activation of protein kinase C βII/ε-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin
    Miyata, Y
    Sato, T
    Yano, M
    Ito, A
    MOLECULAR CANCER THERAPEUTICS, 2004, 3 (07) : 839 - 847